10 Hot Biotech Stocks Under $5
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Amylyx Pharmaceuticals Inc. (AMLX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 6,774,348 | $25,607,035 | +219% | 0.7% |
| 2. | Almitas Capital Ron Mass | 2,032,370 | $7,682,359 | +3% | 1.68% |
| 3. | Citadel Investment Group Ken Griffin | 1,970,704 | $7,449,261 | +4% | 0% |
| 4. | 683 Capital Partners Ari Zweiman | 1,930,000 | $7,295,400 | -4% | 0.45% |
| 5. | Boxer Capital Aaron Davis And Christopher Fuglesang | 1,750,000 | $6,615,000 | 0.56% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.70 | 10,000 | 10,000 | 2025-03-20 | Filing | ||
| $2.53 | 40,000 | 233,464 | 2024-09-12 | Filing | ||
| $2.13 | 50,000 | 55,000 | 2024-09-05 | Filing | ||
| $2.20 | 100,000 | 858,571 | 2024-09-03 | Filing | ||
| $1.89 | 2,250 | 5,000 | 2024-05-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 4,595 | 3,196,648 | 2025-03-03 | Filing | ||
| $3.17 | 4,595 | 3,196,652 | 2025-03-03 | Filing | ||
| $3.12 | 1,611 | 133,310 | 2025-03-03 | Filing | ||
| $3.15 | 4,169 | 134,921 | 2025-02-24 | Filing | ||
| $3.49 | 3,678 | 139,090 | 2025-02-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,643,812 | $17,553,609 | 1.71% | |
| 2. | 2,692,489 | $10,177,608 | 0% | |
| 3. | 2,426,263 | $9,171,274 | 0% | |
| 4. | 2,278,934 | $8,614,370 | 0% | |
| 5. | 1,859,896 | $7,030,408 | 0% |
News See All
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2024 Earnings Call Transcript
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2024 Earnings Call Transcript March 4, 2025Amylyx Pharmaceuticals, Inc. misses on earnings expectations.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2024 Earnings Call Transcript
Operator: Good morning. My name is Alan, and I will be your conference operator today.
7 Best Nano Cap Stocks To Invest In
In one of our recent articles about 8 Most Undervalued Penny Stocks To Buy According To Analysts, we talked about how many analysts are expecting small caps to perform well in a slowing economy.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q2 2024 Earnings Call Transcript
Operator: Good morning. My name is Camille, and I will be your conference operator for today.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript
Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.75071 EPS, expectations were $0.24.
5 Best Value Penny Stocks To Invest In Now
“Furthermore, Five Point Holdings, LLC (NYSE:FPH) (a U.S.-based land development company) launched an exchange offer for its Senior Unsecured Notes, whereby it proposed to pay down $100 million of...
5 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold biotech stocks to buy right now.
Analysts on Wall Street Lower Ratings for These 10 Stocks
In this article, we will discuss the 10 stocks recently downgraded by analysts.
5 Best Biotech Stocks To Buy Under $20
In this article, we are going to take a closer look at five best biotech stocks to buy under $20.
Billionaire Hedge Funds
